Nation Dec 23 FDA says decongestant in many cold medicines doesn’t work. What does help? The Food and Drug Administration recently announced plans to phase out phenylephrine, the key ingredient some cold and allergy pills.
Politics Nov 23 Trump names a Fox News personality, a COVID mandate critic and an anti-vaccine doctor to key public health roles Trump on Friday nominated Dr. Janette Nesheiwat to be the nation's next surgeon general, Dr. Marty Makary to lead the Food and Drug Administration, and doctor and former Rep. Dave Weldon, R-Fla., to lead the Centers for Disease Control and Prevention.
Health Oct 30 McDonald’s E. coli case count rises to 90 as FDA inspects an onion grower linked to recall Federal officials on Wednesday reported more cases of E. coli poisoning among people who ate at McDonald’s, as government investigators seeking the outbreak’s source identified an “onion grower of interest” in Washington state.
Health Jul 29 Blood test for colon cancer gets U.S. regulator approval The test isn't a replacement for colonoscopies, but provides a noninvasive approach to screening.
Health Jul 02 FDA approves 2nd Alzheimer’s drug that can modestly slow dementia Kisunla is not a cure and slows worsening memory and cognitive problems by about seven months.
Health Jun 21 FDA authorizes first menthol-flavored e-cigarettes for adults Parent groups and anti-tobacco advocates are certain to be disappointed by the decision after years of pushing against the availability of flavors like menthol, which are more popular with teens.
Health Jun 13 7 things to know about abortion pill access after the Supreme Court’s decision Despite the ruling, women's access to mifepristone still largely depends on a patchwork of state laws.
Nation Jun 12 Senators grill FDA regulators and Justice Department officials over rise of unauthorized e-cigarettes Government agencies have cracked down on a handful of manufacturers of e-cigarettes, but thousands of unauthorized products continue to be sold in vape shops and convenience stores.
Health Jun 10 FDA advisers back Alzheimer’s drug that can slow disease If the agency agrees with the panel's recommendation, the drug, donanemab, would only be the second Alzheimer’s drug cleared in the U.S. shown to convincingly slow cognitive decline and memory problems due to Alzheimer's.
Health Jun 04 WATCH: FDA expert panel rejects psychedelic drug MDMA as a PTSD treatment The panel of advisers to the Food and Drug Administration cited flawed study data, questionable research conduct and significant drug risks, including the potential for heart problems, injury and abuse.